1-12 of 12
Kate Khair
Close
Sort by
Journal Articles

A Prospective, Observational Study of Bleeding and Quality of Life in Patients with Glanzmann Thrombasthenia in the United Kingdom: Updated Results

Catherine Rea, Thomas York, Ulrike Lorch, Kate Khair, Luke Pembroke, Jigar Amin
Journal: Blood
Blood (2023) 142 (Supplement 1): 5439.
https://doi.org/10.1182/blood-2023-187558
Published: 2023
Journal Articles

Examination and Validation of a Patient-Centric Joint Metric: "Problem Joint"; Empirical Evidence from the CHESS US Dataset

Tom Burke, Idaira Rodriguez Santana, PhD, Pratima Chowdary, MD MBBS, MRCP, FRCPATH, Randall Curtis, MBA, Kate Khair, PhD, Michael Laffan, DM, FRCP, FRCPath, Paul McLaughlin, MSc, MMACP, Declan Noone, MSc, Brian O'Mahony, John Pasi, MB, ChB, PhD FRCP, FRCPath, FRCPCH, Mark W Skinner, JD, Jamie O'Hara, MSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-140950
Published: 2020
Journal Articles

Effect of Moderate and Severe Hemophilia a on Daily Life in Children and Their Caregivers: A CHESS Paediatrics Study Analysis

Kate Khair, PhD, Francis Nissen, Mariabeth Silkey, Tom Burke, Aijing Shang, MD PhD, Martynas Aizenas, Oliver Meier, Jamie O'Hara, MSc, Declan Noone, MSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–45.
https://doi.org/10.1182/blood-2020-134658
Published: 2020
Journal Articles

An Insight into the Impact of Hemophilia a on Daily Life According to Disease Severity: A Preliminary Analysis of the CHESS II Study

Declan Noone, MSc, Francis Nissen, Tao Xu, Tom Burke, Sohaib Asghar, Harpal Dhillon, Martynas Aizenas, Oliver Meier, Jamie O'Hara, MSc, Kate Khair, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–3.
https://doi.org/10.1182/blood-2020-136952
Published: 2020
Journal Articles

Effectiveness and Safety Outcomes in Patients with Hemophilia a Receiving Antihemophilic Factor (Recombinant) for at Least 5 Years in a Real-World Setting: 6-Year Interim Analysis of the Ahead International and German Studies

Dimitrios A. Tsakiris, MD, Johannes Oldenburg, Robert Klamroth, Benoît Guillet, Kate Khair, Angela Huth-Kühne, MD, Karin Kurnik, Stephan Regensburger, Jaco Botha, Alejandro Fernandez, Leilei Tang, Margareth C. Ozelo
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
https://doi.org/10.1182/blood-2020-139873
Published: 2020
Journal Articles

Immune Tolerance Induction with Simoctocog Alfa (Nuwiq ® ) in Six Patients with Severe Haemophilia a and FVIII Inhibitors

Neha Bhatnagar, ND, Kate Khair, Ri Liesner, Alice Wilkinson, Larisa Belyanskaya, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5037.
https://doi.org/10.1182/blood-2018-99-118041
Published: 2018
Journal Articles

Ahead Study: A 3 Year Follow-up of 522 Severe and Moderate Hemophilia a Patients

Johannes Oldenburg, Prof, Dimitrios Tsakiris, Prof, Cedric R. Hermans, MD PhD MRCP, RI Liesner, MD FRCP, FRCPath, MA, MBBChir, Kate Khair, Maria Gabriella Mazzucconi, Prof, Katharina N Steinitz-Trost, PhD, Gerald Spotts, PhD, Armin J Reininger, Prof, Alessandro Gringeri, MD MSc
Journal: Blood
Blood (2016) 128 (22): 3786.
https://doi.org/10.1182/blood.V128.22.3786.3786
Published: 2016
Journal Articles

Observational Study on Safety and Efficacy of Factor Replacement Therapy in the Management of Von Willebrand Disease Patients - Results from an Ongoing Study with a VWF/FVIII Concentrate

Hassan M. Yaish, Kate Khair, Mario von Depka, Maria Sol Cruz, Sylvia Werner, Sigurd Knaub, George M. Rodgers
Journal: Blood
Blood (2016) 128 (22): 4968.
https://doi.org/10.1182/blood.V128.22.4968.4968
Published: 2016
Journal Articles

User Preference Study Of Reconstitution Systems For Factor VIII Products

Kate Khair, PhD, Gabriele Giersdorf, Patricia Guillon, Orie Ono, Lea Kalweit, Brenda Riske
Journal: Blood
Blood (2013) 122 (21): 1674.
https://doi.org/10.1182/blood.V122.21.1674.1674
Published: 2013
Journal Articles

A Two Centre Experience Of Use Of a Dual Virally Inactivated FVIII/VWF Product (Wilate®) In Patients With Von Willebrand Disease

Paul A Batty, MBBS, Kate Khair, PhD, Renu Riat, MBBS, Yun-Han Chen, MBBS, Louise Bowles, Daniel P Hart, MBChB, MRCP, FRCPath, PhD, Ri Liesner, MA MBBChir MD FRCP FRCPath MRCPCH, Sean Platton, Clive Burgess, John Pasi, MBChB, PhD, FRCP, FRCPath
Journal: Blood
Blood (2013) 122 (21): 1112.
https://doi.org/10.1182/blood.V122.21.1112.1112
Published: 2013
Journal Articles

A Neonate with Type 3 Von Willebrands Disease and Life Threatening Bleeding Treated Successfully with a FVIII/VWF Concentrate (wilate®)

Oliver Hegener, PhD, Jemma Efford, Jack L Bartram, Lesley Henderson, Kate Khair
Journal: Blood
Blood (2012) 120 (21): 4633.
https://doi.org/10.1182/blood.V120.21.4633.4633
Published: 2012
Journal Articles

Rituximab Is Effective and Well Tolerated in Children with Hemophila and Factor VIII Inhibitors.

Nichola Cooper, MD, Kate Khair, Mary Mathias, MD, Ri Leisner, MD
Journal: Blood
Blood (2006) 108 (11): 1031.
https://doi.org/10.1182/blood.V108.11.1031.1031
Published: 2006